Which regimen would you recommend for a young patient with node positive, triple positive breast cancer with significant anthracycline-induced cardiomyopathy?

Question inspired by the case of a young woman with LV EF 20-25%, asymptomatic.

Answer from: Medical Oncologist at Academic Institution

I would consider the NeoPact regimen consisting of 6 cycles of docetaxel, carboplatin and pembrolizumab which is currently being directly compared to Keynote 522 regimen in the Scarlet Trial. Given some immune related cardiac risks related to pembrolizumab, i would strongly recommend that the patien...

Please select the option that best describes you:

Which regimen would you recommend for a young patient with node positive, triple positive breast cancer with significant anthracycline-induced cardiomyopathy?

Related Questions